Tele: 561.316.3330
Breaking Medical Device News

Monday, September 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeExtriCARE USAExtriCARE USA Launches Innovative Medical Device Company, Offering Negative Pressure Wound Therapy Solutions

ExtriCARE USA Launches Innovative Medical Device Company, Offering Negative Pressure Wound Therapy Solutions

October 20, 2020

ExtriCARE USA  a national medical device company specializing in the distribution of negative pressure wound therapy (NPWT), officially announces its company launch and new user-centric website.

ExtriCARE USA, led by President Peter Mason, who has over eight years of industry experience, is fostering the future of healthcare with wound care technologies that improve patient outcomes, help clinicians with efficiency and reduce overall costs. NPWT is a modern resource still in its infancy stage. With a tailored and hands-on approach, the ExtriCARE USA team is working diligently to amplify its potential.

“I have a driving passion to develop reliable NPWT products for our network of dealers, which in turn helps patients live a better-quality life,” said Mason. “I am excited to continue building strong partnerships with dealers nationwide, allowing us to support patients and clinicians alike while reaching new heights of growth together.”

To coincide with the company’s launch, ExtriCARE USA has built a new website designed with the user in mind. The website has in-depth information on the ExtriCARE product line, the leadership team and press page with the company’s latest insights.

“With over a decade of experience in wound care, I am fortunate and proud to be a part of such a dynamic and forward-thinking team,” said Gary Schear, Vice President of Sales. “Our patient-first mentality is a driving force, and we hope to continue being a trustworthy lifeline for our providers so that they can be the lifeline for their patients.”

The ExtriCARE USA leadership team, comprised of Peter Mason, Gary Schear and Tony Cheung (Director of Operations), is committed to the future of NPWT. In partnership with Alleva Medical, the company is introducing a new product line that will transform traditional NPWT. The products are designed to be versatile, featuring state-of-the-art technology and optimized software. ExtriCARE USA and Alleva Medical will bring these portable, powerful and adaptive solutions to the market soon.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy